HomeFDA

PLATEAU-X Ti Lateral Lumbar Spacer System Receives FDA 510(k) Clearance

PLATEAU-X Ti Lateral Lumbar Spacer System has received FDA 510(k) clearance. The news was announced today by Life Spine.

PLATEAU-X Ti Lumbar Spacer System launch furthers our commitment of offering micro invasive solutions that are designed to save time, save money, and accelerate patient recovery,” said Mariusz Knap, Sr. Vice President of Sales and Marketing for Life Spine. “PLATEAU-X Ti and all of our titanium implants offer a proprietary surface treatment, Osseo-Loc™. PLATEAU-X Ti improves our already extensive lateral portfolio comprised of PROLIFT® Lateral Expandable Spacer System, CENTRIC® Plier-Style Retractor, and SENTRY® Lateral Plating Systems.”

The PLATEAU-X Ti Lateral Lumbar Spacer enables surgeons to effectively provide anterior column support through a lateral approach. The PLATEAU-X Ti Lateral Lumbar Spacer incorporates a comprehensive set of instruments and implants to streamline the surgical procedure.

Key Features and Benefits of the PLATEAU-X Ti Lateral Lumbar Spacer Include:

• Self-distracting leading edge to ease implant insertion

• Osseo-Loc™ Titanium Surface Treatment Technology

• Available in 0˚, 7˚ and 15˚ lordosis: 40, 45, 50, 55 and 60mm lengths: 8 – 16mm heights: 18, 22 and 26mm widths

• Convex design maximizes vertebrae endplate contact for ideal patient fit

• Large, open graft windows for maximum visibility and bone graft containment

 

SourceLife Spine
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

OTHER NEWS

Zilia Receives FDA Clearance for its Zilia Ocular™ FC Retinal Camera

"Receiving this first FDA clearance for our retinal camera is not just a milestone, it's a leap forward in our quest to safeguard the vision of millions," said Dr. Patrick Sauvageau, optometrist, CEO, and co-founder of Zilia. "We're now focused on obtaining De Novo classification for ocular oximetry, a breakthrough biomarker that promises to revolutionize how we diagnose and manage a variety of ocular conditions."

Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances

The recent FDA clearances included Brainomix 360 e-CTP and Brainomix 360 e-MRI, both software modules that can support thrombolysis and thrombectomy treatment decisions, particularly for late-window patients who present to hospital more than 6-12 hours after stroke onset.

GE HealthCare Announces New Version of Digital Expert Access, the First FDA 510(k)-Cleared Device to Enable Remote Patient Scanning, and Exclusive Distribution Agreement with...

IONIC Health’s 510(k)-pending nCommand Lite technology is designed to include vendor-agnostic remote scanning capabilities. This strategic collaboration’s goal is to enable GE HealthCare to provide a multi-vendor, multi-modality remote scanning solution to healthcare systems and patients around the globe.

Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

Silmitasertib works by inhibiting CK2 protein kinase, which have implicated in regulation of several signaling pathways that are important for innate immune responses. CK2 modulates inflammatory pathways, including NF-κB, PI3K–Akt–mTOR, and JAK–STAT.

FloSpine Revolutionizes Treatment for Spinal Stenosis with FDA Clearance of KeyLift™ System

"This is the culmination of years of research and development to deliver a medical device that helps improve the lives of patients suffering from spinal stenosis. Our recent move to larger premises in the Research Park at FAU will allow us to train our surgical and distribution partners to become increasingly competitive in the spinal implant device market,” said Peter Harris, founder and CEO of FloSpine.

Medical Device News Magazine

Editorial Contact: mdnewsmagazine@infomeddnews.com

Medical Device News Magazine can help promote your medical devices, technologies, products or services. Advertising Contact: advmdn@infomeddnews.com

Telephone

© Copyright 2022 Medical Device News Magazine, is a division of PTM Healthcare Marketing, Inc

By using this website you agree to accept Medical Device News Magazine Privacy Policy